Skip to main content

SV Health Investors — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

76
Companies
$3.3B
Total invested
$43.8M
Avg. check
19
Industries
Biotechnology 22Health Care 15Medical 8Therapeutics 8Pharmaceutical 4Health Diagnostics 4+13 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 25–48 of 76
Eyebiotech
November 2023

Eyebiotech is an ophthalmology biotechnology company that specializes in therapies for eye diseases.

Biotechnology · New York$65.0M Series A
Vittoria Biotherapeutics
November 2023

Vittoria Biotherapeutics is a gene-edited cell therapeutics company.

Bioinformatics · Philadelphia$15.0M Venture - Series Unknown
Sitryx Therapeutics
September 2023

Sitryx is a biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.

Biotechnology · Oxford$39.0M Series A
Pulmocide
December 2022

Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.

Biotechnology · London$52.0M Series C
Rondo Therapeutics
March 2022

Rondo Therapeutics creates novel bispecific antibodies that activate the immune system to fight cancer.

Biopharma · Hayward$67.0M Series A
Quell Therapeutics
November 2021

Quell Therapeutics is a cell therapy company

Association · London$156.0M Series B
Zerigo Health
October 2021

Clarify Medical is a developer of a handheld medical device used to treat psoriasis, eczema, and vitiligo .

Biopharma · La Jolla$43.0M Series B
Mestag Therapeutics
March 2026

Mestag Therapeutics is a biotechnology company that develops new therapies for diseases using fibroblast technology.

Biotechnology · Cambridge$40.0M Series Unknown
Transposon Therapeutics
March 2026

Transposon Therapeutics specializes in developing therapeutics for debilitating and life-threatening diseases.

Biotechnology · Westport$22.0M Grant
TRex Bio
January 2026

TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.

Bioinformatics · South San Francisco$50.0M Series Unknown
Imbria Pharmaceuticals
November 2025

Imbria Pharmaceuticals is a clinical stage biotechnology company developing novel therapies for cardiometabolic diseases.

Biotechnology · BostonSeries B
X4 Pharmaceuticals
October 2025

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

Biotechnology · Cambridge$155.3M Post Ipo Equity
KalVista Pharmaceuticals
September 2025

KalVista Pharmaceuticals is an ophthalmology company focused on developing drugs for the treatment of diabetic macular edema (DME).

Biotechnology · Cambridge$125.0M Post Ipo Debt
Dualitas Therapeutics
September 2025

Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders

Biotechnology · San Francisco$65.0M Series A
Draig Therapeutics
June 2025

Draig Therapeutics is a clinical-stage biopharmaceutical startup.

Biopharma · Cardiff$140.0M Series A
Alpheus Medical
May 2025

Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.

Biotechnology · Oakdale$52.0M Series B
Therini Bio
May 2025

Therini Bio specializes in fibrin-targeting therapies to treat inflammatory neurological and retinal diseases.

Biotechnology · San Francisco$39.0M Series A
AdvanCell
April 2025

AdvanCell is a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer treatment.

Biotechnology · Sydney$11.3M Grant
Perfuze
March 2025

Perfuze is a medical device company developing catheter-based aspiration technology to treat acute ischemic stroke.

Health Care · Newcastle$23.9M Series Unknown
Ria Health
February 2025

Ria Health is an online platform providing telehealth services for alcohol use disorder.

Health Care · San Francisco$6.5M Series B
Harness Therapeutics
January 2025

Harness Therapeutics is a developer of a platform for physiological upregulation of proteins using targeted translation enhancers, SINEUPs.

Biotechnology · CambridgeSeries Unknown
Brixton Biosciences
October 2024

Brixton Biosciences is a clinical-stage life sciences company that develops therapies for chronic and acute pain.

Biotechnology · Cambridge$2.0M Grant
Enara Bio
October 2024

Ervaxx is illuminating the immune interface to develop new cancer therapies.

Biotechnology · London$32.5M Series B
LOQUS23 THERAPEUTICS
October 2024

LoQus23 is a DDF-formed company focussing on targeting DNA damage repair pathways to treat Huntington’s disease.

Biotechnology · London$46.4M Series A

Where SV Health Investors invests

Biotechnology22
Health Care15
Medical8
Therapeutics8
Pharmaceutical4
Health Diagnostics4

About SV Health Investors's portfolio

How many companies has SV Health Investors invested in?▸

SV Health Investors has invested in 76 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does SV Health Investors invest in?▸

SV Health Investors's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 19 different industry categories.

What is SV Health Investors's largest investment?▸

Among tracked funding rounds, Quell Therapeutics received $156.0M in a Series B round. SV Health Investors's total known invested capital is $3.3B.

What is the average investment size for SV Health Investors?▸

SV Health Investors's average investment size is $43.8M across its portfolio of 76 companies.

What are SV Health Investors's most recent investments?▸

Recent SV Health Investors portfolio additions include Eyebiotech, Vittoria Biotherapeutics, Sitryx Therapeutics, Pulmocide, Rondo Therapeutics. These companies were founded in 2020 or later.

Reach the founders behind these 76 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →